Literature DB >> 2438342

The immune response to bacterial dextrans. V. A "dominant" idiotype in IgCHb mice.

I Lundkvist, F Ivars, D Holmberg, A Coutinho.   

Abstract

A battery of syngeneic monoclonal anti-idiotypic antibodies was prepared against a monoclonal C57BL/6 anti-Dextran B512 antibody (17-9). Two such anti-idiotypes were shown to bind to sites on the 17-9 molecule which are related to the Dex-binding site and were used to characterize the anti-Dex antibody response in a number of inbred mouse strains. The results show that the 17-9 idiotype is recurrently expressed by all mice carrying the IgCHb haplotype, regardless of H-2 or background genes, and that this idiotype accounts for roughly one-half of the primary, specific response to Dex B512 in C57BL/6 mice. Backcross analysis confirmed the allotype-linkage of idiotype expression in the antibody response. Mice carrying other allotypes, however, had detectable levels of the 17-9 idiotype in normal sera, which was not associated with anti-Dex antibody activity and was not raised by specific immunization. Together with previous observations, these results characterize a second "recurrent" idiotype in the anti-alpha,1-6 response of IgCHb mice, both of which are expressed in the normal serum of all mouse strains tested.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2438342

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  2 in total

1.  Anti-anti-idiotypic (Ab3) antibodies that bind progesterone-11alpha-bovine serum albumin differ in their combining sites from antibodies raised directly against the antigen.

Authors:  R D Kirsch; D Beale; M He; A L Corper; U Krawinkel-Brenig; M J Taussig
Journal:  Immunology       Date:  2000-06       Impact factor: 7.397

2.  Understanding thymus-independent antigen-induced reduction of thymus-dependent immune responses.

Authors:  Karin Lindroth; Elena Fernández Mastache; Izaura Roos; Africa González Fernández; Carmen Fernández
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.